硝基呋喃妥因三联抗生素糊剂用于再生牙髓的生物学性能
本研究在体外比较了含硝基呋喃妥因(4 mg/g)、环丙沙星(1 mg/g)和甲硝唑(5 mg/g)的实验性三联抗生素糊剂(EXP)与Hoshino糊剂及氢氧化钙对牙髓干细胞的影响。EXP维持约75%代谢活性,细胞毒性低于Hoshino配方,溶酶体完整性优于Hoshino 1、Hoshino 5和Ca(OH)2。
要点
- EXP对牙髓干细胞代谢活性约75%,细胞毒性低于Hoshino配方。
- EXP溶酶体完整性显著优于Hoshino 1、Hoshino 5和Ca(OH)2。
- EXP与Hoshino 1仅IP-10区别于对照,药物组间无差异。
核心结论
- 在本实验条件下,硝基呋喃妥因基EXP对牙髓干细胞的细胞相容性优于传统Hoshino配方,细胞活力保存优于测试的Ca(OH)2糊剂。
研究设计与样本
- 体外研究比较EXP、Hoshino糊剂(环丙沙星、甲硝唑、米诺环素1或5 mg/g)和Ca(OH)2糊剂。
- 人牙髓干细胞暴露于0.2 g/mL提取物24小时。
主要发现
- EXP维持约75%代谢活性,细胞毒性表现较Hoshino配方轻。
- Neutral Red实验中EXP溶酶体完整性显著高于Hoshino 1、Hoshino 5和Ca(OH)2。
- Live/Dead成像显示EXP保存更多活细胞。
- Hoshino 5显著降低IL-2、IL-5和IL-8;Ca(OH)2升高IL-6并降低IL-1β、IL-15、IL-17、VEGF和MIP-1β。
- Hoshino 1和EXP仅IP-10与未处理对照不同,药物处理组间无差异。
关键数值与推荐
- EXP组成:硝基呋喃妥因4 mg/g、环丙沙星1 mg/g、甲硝唑5 mg/g。
- Hoshino糊剂含环丙沙星、甲硝唑和米诺环素,浓度1或5 mg/g。
- 提取物浓度0.2 g/mL,暴露24小时。
- 统计采用Kruskal-Wallis检验及Dunn-Holm事后检验。
临床怎么用
- EXP可作为再生牙髓程序的候选药物进一步研究,当前证据限于体外细胞实验。
局限性
- 研究为体外设计,未涉及临床感染模型或体内组织再生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: This study evaluated an experimental triple antibiotic paste (EXP) composed of nitrofurantoin (4 mg/g), ciprofloxacin (1 mg/g) and metronidazole (5 mg/g) for regenerative endodontic procedures (REPs), using calcium hydroxide [Ca(OH)2] as a reference. METHODS: EXP, commercial Hoshino pastes containing ciprofloxacin, metronidazole and minocycline at 1 or 5 mg/g, and a Ca(OH)2 paste were compared in human dental pulp stem cells exposed for 24 h to 0.2 g/mL extracts. Cytotoxicity was assessed by XTT, Neutral Red, Crystal Violet and qualitative Live/Dead imaging. The concentrations of 27 cytokines, chemokines and growth factors in culture supernatants were quantified by multiplex immunoassay. Data were analysed using Kruskal-Wallis with Dunn-Holm post hoc testing. RESULTS: EXP maintained approximately 75% metabolic activity and showed a less severe cytotoxic profile than the Hoshino formulations. In Neutral Red, EXP preserved significantly greater lysosomal integrity than Hoshino 1, Hoshino 5 and Ca(OH)2. Live/Dead imaging supported greater preservation of viable cells with EXP. Hoshino 5 significantly reduced IL-2, IL-5 and IL-8, whereas Ca(OH)2 increased IL-6 and reduced IL-1β, IL-15, IL-17, VEGF and MIP-1β. Hoshino 1 and EXP only differed from untreated control on IP-10, and no differences occurred among medicament-treated groups. CONCLUSION: The nitrofurantoin-based EXP paste demonstrated comparatively improved cytocompatibility toward DPSCs relative to the conventional Hoshino formulations and greater preservation of cell viability than the tested Ca(OH)2 paste under the present experimental conditions. Together with its previously demonstrated antimicrobial activity, these findings support EXP as a promising candidate for further investigation in REPs.
引用
- Scelza MFZ, Neto PS, Rocha NRS, et al. Biological Performance of a Nitrofurantoin-Based Triple Antibiotic Paste for Regenerative Endodontics. Int Endod J. 2026. PMID: 42775408. doi:10.1111/iej.70276
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。